Eli Lilly – Startup Investor Profile

Eli Lilly is a pharma company focused on developing medicines for diabetes, cancer, immunology, and other major health areas.

Location: Indianapolis

Country:

Investment Regions:

Investment Stages: late-stage, seed

Website: https://www.lilly.com/

AI Reasoning: Multiple reputable news sources in late Oct-Nov 2025 report Lilly Ventures and Eli Lilly participating in many corporate venture investments in 2025, including a BioPharma Dive item (Oct 31, 2025) noting Eli Lilly was involved in 13 private venture rounds in 2025, and reports of partnerships/activities with startups in Sep-Oct 2025 (e.g., a Sep 4, 2025 collaboration reported by GeekWire). The most recent known investments are within the past month, i.e., less than three months ago, indicating very recent activity. The startup explicitly mentioned in reporting of a collaboration is a Seattle biotech spinoff from UW Baker Lab. The elapsed time since the last reported investments is under three months, so the appropriate tag is very-active.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.